tiprankstipranks
Advertisement
Advertisement

HK:2197 Stock Latest News

Clover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure
Company AnnouncementsClover Biopharmaceuticals Details Capped Payment Deal With Gavi, Easing US$224 Million Exposure
7d ago
2197
Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines
PremiumCompany Announcements
Clover Biopharmaceuticals Completes Enrollment in Phase 2 Trial for Combination Respiratory Vaccines
10d ago
2197
Clover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance
PremiumCompany Announcements
Clover Biopharmaceuticals Grants Over 19 Million Equity Awards to Align Pay With Performance
12d ago
2197
Clover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines
PremiumCompany Announcements
Clover Narrows Loss as It Cuts Costs and Refocuses on Respiratory Vaccines
14d ago
2197
Clover posts strong RSV re-vaccination data in head-to-head trial with GSK
PremiumCompany Announcements
Clover posts strong RSV re-vaccination data in head-to-head trial with GSK
15d ago
2197
Clover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration
PremiumCompany AnnouncementsClover Biopharmaceuticals Strikes Cap-Limited Settlement With Gavi to End Arbitration
18d ago
2197
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend
Premium
Company Announcements
Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend
27d ago
2197
Clover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults
Premium
Company Announcements
Clover Launches Phase 2 Trial of Combination Respiratory Vaccines in Older Adults
3M ago
2197
Clover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines
PremiumCompany Announcements
Clover Biopharmaceuticals Reports Positive Phase I Results for Respiratory Vaccines
6M ago
2197
Clover Biopharmaceuticals Reports Interim Financial Results for 2025
PremiumCompany Announcements
Clover Biopharmaceuticals Reports Interim Financial Results for 2025
8M ago
2197
Clover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal
PremiumCompany Announcements
Clover Biopharmaceuticals to Review Interim Financial Results and Dividend Proposal
8M ago
2197
Clover Biopharmaceuticals Announces Board and Committee Changes
PremiumCompany Announcements
Clover Biopharmaceuticals Announces Board and Committee Changes
9M ago
2197
Clover Biopharmaceuticals Strengthens Governance with New Nomination Committee
PremiumCompany AnnouncementsClover Biopharmaceuticals Strengthens Governance with New Nomination Committee
9M ago
2197
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement
Premium
Company Announcements
Clover Biopharmaceuticals Announces Unanimous AGM Results and Director Retirement
10M ago
2197
Clover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines
Premium
Company Announcements
Clover Biopharmaceuticals Launches Phase I Trial for New Respiratory Vaccines
10M ago
2197
Clover Biopharmaceuticals Ends Distribution Agreement with Adimmune
PremiumCompany Announcements
Clover Biopharmaceuticals Ends Distribution Agreement with Adimmune
10M ago
2197
Clover Biopharmaceuticals Faces Arbitration Over $224 Million Claim
PremiumCompany Announcements
Clover Biopharmaceuticals Faces Arbitration Over $224 Million Claim
10M ago
2197
Clover Biopharmaceuticals Announces 2025 Annual General Meeting Agenda
PremiumCompany Announcements
Clover Biopharmaceuticals Announces 2025 Annual General Meeting Agenda
11M ago
2197
Clover Biopharmaceuticals Grants Options and RSUs to Boost Talent Retention
PremiumCompany Announcements
Clover Biopharmaceuticals Grants Options and RSUs to Boost Talent Retention
1y ago
2197
Clover Biopharmaceuticals Reports 2024 Annual Results with Strategic Cost Reductions
PremiumCompany AnnouncementsClover Biopharmaceuticals Reports 2024 Annual Results with Strategic Cost Reductions
1y ago
2197
Clover Biopharmaceuticals Postpones Board Meeting to Finalize Annual Results
Premium
Company Announcements
Clover Biopharmaceuticals Postpones Board Meeting to Finalize Annual Results
1y ago
2197
Clover Biopharmaceuticals Disputes Gavi’s Termination and Repayment Claim
Premium
Company Announcements
Clover Biopharmaceuticals Disputes Gavi’s Termination and Repayment Claim
1y ago
2197

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >